Singapore Medical Group kept at 'buy' on strong FY18 results, CHAS ...
SINGAPORE (Feb 21): RHB Research is maintaining Singapore Medical Group (SMG) at “buy” on news that shareholder CHA Healthcare Singapore (CHAS) is raising its stake in the group. On Wednesday, SMG ...
read more